P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES

MLA

Michael Robert Savona, et al. “P735: Efficacy and Safety of Oral Decitabine/Cedazuridine (Astx727) in the Cmml Subpopulation from Phase 2 and Ascertain Phase 3 Studies.” HemaSphere, vol. 7, Aug. 2023, p. e1342620. EBSCOhost, https://doi.org/10.1097/01.HS9.0000969844.13426.20.

APA

Michael Robert Savona, James K Mccloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, Prapti A. Patel, Mitchell Sabloff, Mary-Margaret Keating, Nancy Y Zhu, Nashat Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy Dezern, Casey L Oconnell, Gail Roboz, … Guillermo Garcia-Manero. (2023). P735: Efficacy and Safety of Oral Decitabine/Cedazuridine (Astx727) in the Cmml Subpopulation from Phase 2 and Ascertain Phase 3 Studies. HemaSphere, 7, e1342620. https://doi.org/10.1097/01.HS9.0000969844.13426.20

Chicago

Michael Robert Savona, James K Mccloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, et al. 2023. “P735: Efficacy and Safety of Oral Decitabine/Cedazuridine (Astx727) in the Cmml Subpopulation from Phase 2 and Ascertain Phase 3 Studies.” HemaSphere 7 (August): e1342620. doi:10.1097/01.HS9.0000969844.13426.20.